These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


629 related items for PubMed ID: 11351773

  • 1. Managing influenza: amantadine, rimantadine and beyond.
    Fleming DM.
    Int J Clin Pract; 2001 Apr; 55(3):189-95. PubMed ID: 11351773
    [Abstract] [Full Text] [Related]

  • 2. A new antiviral agent for influenza--is there a clinical niche?
    Couch RB.
    N Engl J Med; 1997 Sep 25; 337(13):927-8. PubMed ID: 9302309
    [No Abstract] [Full Text] [Related]

  • 3. Inhaled zanamivir for the prevention of influenza in families. Zanamivir Family Study Group.
    Hayden FG, Gubareva LV, Monto AS, Klein TC, Elliot MJ, Hammond JM, Sharp SJ, Ossi MJ, Zanamivir Family Study Group.
    N Engl J Med; 2000 Nov 02; 343(18):1282-9. PubMed ID: 11058672
    [Abstract] [Full Text] [Related]

  • 4. Updated treatment for influenza A and B.
    Montalto NJ, Gum KD, Ashley JV.
    Am Fam Physician; 2000 Dec 01; 62(11):2467-76. PubMed ID: 11130232
    [Abstract] [Full Text] [Related]

  • 5. Zanamivir: from drug design to the clinic.
    Elliott M.
    Philos Trans R Soc Lond B Biol Sci; 2001 Dec 29; 356(1416):1885-93. PubMed ID: 11779388
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Zanamivir: an influenza virus neuraminidase inhibitor.
    Colman PM.
    Expert Rev Anti Infect Ther; 2005 Apr 29; 3(2):191-9. PubMed ID: 15918777
    [Abstract] [Full Text] [Related]

  • 12. Antiviral management of seasonal and pandemic influenza.
    Hayden FG, Pavia AT.
    J Infect Dis; 2006 Nov 01; 194 Suppl 2():S119-26. PubMed ID: 17163384
    [Abstract] [Full Text] [Related]

  • 13. Antivirals and influenza: frequency of resistance.
    Monto AS.
    Pediatr Infect Dis J; 2008 Oct 01; 27(10 Suppl):S110-2. PubMed ID: 18820569
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. What is the best antiviral agent for influenza infection?
    Fagan HB, Moeller AH.
    Am Fam Physician; 2004 Oct 01; 70(7):1331-2. PubMed ID: 15508545
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Safety and efficacy of nebulized zanamivir in hospitalized patients with serious influenza.
    Ison MG, Gnann JW, Nagy-Agren S, Treannor J, Paya C, Steigbigel R, Elliott M, Weiss HL, Hayden FG, NIAID Collaborative Antiviral Study Group.
    Antivir Ther; 2003 Jun 01; 8(3):183-90. PubMed ID: 12924534
    [Abstract] [Full Text] [Related]

  • 19. Clinical efficacy and safety of the orally inhaled neuraminidase inhibitor zanamivir in the treatment of influenza: a randomized, double-blind, placebo-controlled European study.
    Mäkelä MJ, Pauksens K, Rostila T, Fleming DM, Man CY, Keene ON, Webster A.
    J Infect; 2000 Jan 01; 40(1):42-8. PubMed ID: 10762110
    [Abstract] [Full Text] [Related]

  • 20. Flu-fighting options: decisions, decisions...
    Rosen DS.
    Health News; 2000 Dec 01; 6(12):4. PubMed ID: 11142939
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 32.